Sotalol Hydrochloride Injection
Product Images NDC 69724-112

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 69724-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Altathera Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Figure 001)

Figure (Figure 001)
The text is a graph showing the comparison between BETAPACE AF and Placebo for recurrence-free sunival. The x-axis shows Time in Days and the y-axis shows the percentage of recurrence-free activity. The graph indicates that BETAPACE AF has a higher percentage of recurrence-free Sunival compared to Placebo. The P-value obtained through Log-Rank test is not specified.*
FDA Label Image

Figure (Figure 002)

Figure (Figure 002)
FDA Label Image

Figure (Figure 003)

Figure (Figure 003)
FDA Label Image

Carton Image (Sotalol Iv Carton)

Carton Image (Sotalol Iv Carton)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.